Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.1.25 (
triphosphatase
)
1,529
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Insulin-stimulated translocation of the glucose transporter GLUT4 to the plasma membrane in muscle and fat cells depends on the phosphatidylinositide 3-kinase/Akt pathway. The downstream target AS160/
TBC1D4
is phosphorylated upon insulin stimulation and contains a TBC domain (Tre-2/Bub2/Cdc16) that is present in most Rab guanosine
triphosphatase
-activating proteins.
TBC1D4
associates with GLUT4-containing membranes under basal conditions and dissociates from membranes with insulin. Here we show that the association of
TBC1D4
with membranes is required for its inhibitory action on GLUT4 translocation under basal conditions. Whereas the insulin-dependent dissociation of
TBC1D4
from membranes was not required for GLUT4 translocation, its phosphorylation was essential. Many agonists that stimulate GLUT4 translocation failed to trigger
TBC1D4
translocation to the cytosol, but in most cases these agonists stimulated
TBC1D4
phosphorylation at T642, and their effects on GLUT4 translocation were inhibited by overexpression of the
TBC1D4
phosphorylation mutant (
TBC1D4
-4P). We postulate that
TBC1D4
acts to impede GLUT4 translocation by disarming a Rab protein found on GLUT4-containing-membranes and that phosphorylation of
TBC1D4
per se is sufficient to overcome this effect, allowing GLUT4 translocation to the cell surface to proceed.
...
PMID:Regulation of glucose transporter 4 translocation by the Rab guanosine triphosphatase-activating protein AS160/TBC1D4: role of phosphorylation and membrane association. 1880 32